Literature DB >> 17760870

Prolyl hydroxylase inhibitors delay neuronal cell death caused by trophic factor deprivation.

David J Lomb1, Jennifer A Straub, Robert S Freeman.   

Abstract

Nerve growth factor (NGF) serves a critical survival-promoting function for developing sympathetic neurons. Following removal of NGF, sympathetic neurons undergo apoptosis characterized by the activation of c-Jun N-terminal kinases (JNKs), up-regulation of BH3-only proteins including BcL-2-interacting mediator of cell death (BIM)(EL), release of cytochrome c from mitochondria, and activation of caspases. Here we show that two small-molecule prolyl hydroxylase inhibitors frequently used to activate hypoxia-inducible factor (HIF) - ethyl 3,4-dihydroxybenzoic acid (DHB) and dimethyloxalylglycine (DMOG) - can inhibit apoptosis caused by trophic factor deprivation. Both DHB and DMOG blocked the release of cytochrome c from mitochondria after NGF withdrawal, whereas only DHB blocked c-Jun up-regulation and phosphorylation. DHB, but not DMOG, also attenuated the induction of BIM(EL) in NGF-deprived neurons, suggesting a possible mechanism whereby DHB could inhibit cytochrome c release. DMOG, on the other hand, was substantially more effective at stabilizing HIF-2alpha and inducing expression of the HIF target gene hexokinase 2 than was DHB. Thus, while HIF prolyl hydroxylase inhibitors can delay cell death in NGF-deprived neurons, they do so through distinct mechanisms that, at least in the case of DHB, are partly independent of HIF stabilization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17760870     DOI: 10.1111/j.1471-4159.2007.04873.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

2.  Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α.

Authors:  Molly E Ogle; Xiaohuan Gu; Alyssa R Espinera; Ling Wei
Journal:  Neurobiol Dis       Date:  2011-10-29       Impact factor: 5.996

3.  The interferon response as a common final pathway for many preconditioning stimuli: unexpected crosstalk between hypoxic adaptation and antiviral defense.

Authors:  Saravanan S Karuppagounder; Yujia Zhai; Yingxin Chen; Rongrong He; Rajiv R Ratan
Journal:  Cond Med       Date:  2018-06-15

4.  Nerve Growth Factor, Muscle Afferent Receptors and Autonomic Responsiveness with Femoral Artery Occlusion.

Authors:  Jianhua Li; Jihong Xing; Jian Lu
Journal:  J Mod Physiol Res       Date:  2014

5.  Femoral Artery Occlusion Increases Muscle Pressor Reflex and Expression of Hypoxia-Inducible Factor-1α in Sensory Neurons.

Authors:  Wei Gao; Jianhua Li
Journal:  J Cardiovasc Dis       Date:  2013-10

6.  Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential.

Authors:  Hao Ding; You-Shui Gao; Yang Wang; Chen Hu; Yuan Sun; Changqing Zhang
Journal:  Stem Cells Dev       Date:  2014-01-24       Impact factor: 3.272

7.  In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation.

Authors:  Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Thong C Ma; Rachel E Speer; Natalya A Smirnova; Irina G Gazaryan; Rajiv R Ratan
Journal:  J Neurosci Res       Date:  2013-03-04       Impact factor: 4.164

8.  Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.

Authors:  Jian Fu; Mark B Taubman
Journal:  J Biol Chem       Date:  2010-01-10       Impact factor: 5.157

Review 9.  Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke.

Authors:  Rachel E Speer; Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Amit Kumar; David Brand; Natalya Smirnova; Irina Gazaryan; Soah J Khim; Rajiv R Ratan
Journal:  Free Radic Biol Med       Date:  2013-01-31       Impact factor: 7.376

10.  Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons.

Authors:  David J Lomb; Lynette A Desouza; James L Franklin; Robert S Freeman
Journal:  Mol Pharmacol       Date:  2009-02-09       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.